Theobromine
 OpenBabel02212023462D

 13 14  0  0  0  0  0  0  0  0999 V2000
   -0.3984    0.7541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1435   -0.0305    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6284   -0.6979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1435   -1.3654    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6411   -1.1104    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    0.6411   -0.2854    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0
    1.3556    0.1271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3556    0.9521    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.0701   -0.2854    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.0701   -1.1104    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7845   -1.5229    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3556   -1.5229    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3556   -2.3479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  2  6  1  0  0  0  0
  3  4  1  0  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  5 12  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  2  0  0  0  0
  7  9  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 10 12  1  0  0  0  0
 12 13  1  0  0  0  0
M  END
>  <CdId>
373

>  <Mol Weight>
180.164

>  <Formula>
C7H8N4O2

>  <ID>
T0625

>  <Name>
Theobromine

>  <Synonyms>
3, 7-Dimethylxanthine

>  <CAS>
83-67-0

>  <Approved status>
FDA

>  <Disease>
Cardiovascular system

>  <Indication>
Arteriosclerosis; Certain?Vascular Diseases; ?Angina Pectoris; And?Hypertension

>  <Pathways>
Metabolism; Neuroscience

>  <Target>
AChR inhibitor; PDE inhibitor

>  <Receptor>
Adenosine receptor; PDE

$$$$
